Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness

SIMPLE SUMMARY: The main problem encountered in the management of prostate cancer (PCa) is the inability to distinguish slow-growing indolent tumors from aggressive tumors. It is therefore important to explore non-invasive assays for the early detection of this aggressive subtype, when it can still...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Ruiz-Plazas, Xavier, Altuna-Coy, Antonio, Alves-Santiago, Marta, Vila-Barja, José, García-Fontgivell, Joan Francesc, Martínez-González, Salomé, Segarra-Tomás, José, Chacón, Matilde R.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7826893/
https://ncbi.nlm.nih.gov/pubmed/33440913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13020250
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars